Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05004779
Other study ID # HangangSHH-13
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date August 10, 2021
Est. completion date April 20, 2022

Study information

Verified date July 2021
Source Hangang Sacred Heart Hospital
Contact Cheong Hoon Seo, M.D.
Phone +82 2 2639 5738
Email chseomd@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study was to determine the effect of combined treatment using nonablative laser and human stem cell media (HSCM) on the regeneration of hypertrophic scars that occurred after burns.


Description:

The purpose of this study was to determine the effect of combined treatment using nonablative laser and human stem cell media (HSCM) on the regeneration of hypertrophic scars that occurred after burns. Nonablative laser treatment was performed on 30 patients with hypertrophic scars on both sides of the same part of the body. Immediately after the laser treatment, the hypertrophic scars of right side to which HSCM was applied and the left side with the same body position were defined as a control scar, and normal saline was applied. Over the next 6 days, HSCM and moisturizer were applied on the scars of right side, and only moisturizer was applied on the control scar of left side. Laser treatment was performed three times on the hypertrophic scar at 4 weeks intervals. The skin test on hypertrophic scar was evaluated before laser treatment and re-evaluated on the 7the day after the 3rd laser treatment. The thickness was measured with a ultrasonic wave equipment (128 BW1 Medison, Korea). Mexameter® (MX18, Courage-Khazaka Electronics GmbH, Germany) was used to measure melanin levels and the severity of erythema. The higher values indicating a darker and redder skin. Transepidermal water loss (TEWL) was measured with a Tewameter® (Courage-Khazaka Electronic GmbH, Germany), which is used for evaluating water evaporation. Sebum in the scars was measured with the Sebumeter® (Courage-Khazaka Electronic GmbH, Germany). The measurement is based on the principle of grease-spot photometry using a cassette with its special tape. A microprocessor calculates the result, which is shown on the display in μg/cm2. Elasticity was measured using Cutometer SEM 580® (Courage-Khazaka Electronic GmbH, Cologne, Germany), which applies negative pressure (450 mbar) on the skin. The numeric values (mm) of the skin's distortion is presented as the elasticity (Table 1). Two seconds of negative pressure of 450 mbar is followed by 2 s of recess, and this consists of a complete cycle. Three measurement cycles were conducted, and the average values were obtained. To evaluate the effect of HSCM, investigators compared the skin test results (thickness, melanin, erythema, TEWL, sebum, and skin elasticity levels) between the right side and control side, from baseline measures immediately before the laser treatment and measures on the 7the day after the 3rd laser treatment. Outcome measurements and data analyses were performed by a trained and blinded outcome assessor who was not involved in the intervention. Possible complications (pain, ecchymosis, skin abrasion, and swelling) were observed.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 30
Est. completion date April 20, 2022
Est. primary completion date December 31, 2021
Accepts healthy volunteers No
Gender All
Age group 19 Years to 75 Years
Eligibility Inclusion Criteria: - partial or full-thickness burns that healed spontaneously or required skin grafting - with hypertrophic scars on the right and left sides of the same body part Exclusion Criteria: - Patients with open wounds or infection on the burn scars - those taking steroids for the scars - with allergies to topical anesthetic cream - those who were pregnant - undergoing any other medical treatment or condition affecting wound healing (e.g., diabetes)

Study Design


Intervention

Procedure:
human stem cell conditioned media was applied after non-ablative laser therapy
After laser treatment on hypertrophic scars, human stem cell media was applied to one side
normal saline was applied after non ablative laser therapy
physiological saline was applied to the other side.

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Hangang Sacred Heart Hospital National Research Foundation of Korea

References & Publications (3)

Jayaraman P, Nathan P, Vasanthan P, Musa S, Govindasamy V. Stem cells conditioned medium: a new approach to skin wound healing management. Cell Biol Int. 2013 Oct;37(10):1122-8. doi: 10.1002/cbin.10138. Epub 2013 Jun 24. — View Citation

Onur Erol O, Agaoglu G, Jawad MA. Combined Non-Ablative Laser and Microfat Grafting for Burn Scar Treatment. Aesthet Surg J. 2019 Mar 14;39(4):NP55-NP67. doi: 10.1093/asj/sjy291. — View Citation

Park IS. Enhancement of Wound Healing by Conditioned Medium of Adipose-Derived Stromal Cell with Photobiomodulation in Skin Wound. Int J Stem Cells. 2021 May 30;14(2):212-220. doi: 10.15283/ijsc20175. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary scar thickness (cm) The thickness was measured with a ultrasonic wave equipment baseline
Primary change from baseline scar thickness at 3 months (cm) the change of scar thickness was measured with a ultrasonic wave equipment after 3 months intervention
Secondary melanin levels (arbitraty units; AU) the higher values indicating a darker baseline
Secondary change from baseline melanin level at 3 months (arbitraty units; AU) the higher values indicating a darker after 3 months intervention
Secondary erythema level (arbitraty units; AU) the higher values indicating a redder skin baseline
Secondary change from baseline erythema level at 3 months (arbitraty units; AU) the higher values indicating a redder skin after 3 months intervention
Secondary transepidermal water loss (g/h/m2) the higher the number, the more dry the skin is. baseline
Secondary change from baseline transepidermal water loss at 3 months (g/h/m2) the higher the number, the more dry the skin is. after 3 months intervention
Secondary Sebum level (µg sebum/cm2) A microprocessor calculates the result, which is shown on the display in µg/cm2. The higher the number, the more oily the skin is. baseline
Secondary change from baseline sebum level at 3 months (µg sebum/cm2) A microprocessor calculates the result, which is shown on the display in µg/cm2. The higher the number, the more oily the skin is. after 3 months intervention
See also
  Status Clinical Trial Phase
Completed NCT03376620 - Role of Topical Putrescine (Fibrostat) for Prevention of Hypertrophic Scars in Mammoplasty Patients Phase 3
Terminated NCT03935594 - Use of Autologous Platelet-Rich Plasma to Treat Hypertrophic Burn Scars Phase 2
Recruiting NCT03561376 - Zinc Oxide Versus Petrolatum Following Skin Surgery Early Phase 1
Recruiting NCT06033430 - Effectiveness of Dry Needling in Linear Scar Tissue N/A
Recruiting NCT03631368 - Treatment of Hypertrophic Scars With Intradermal Botox Phase 2
Completed NCT03630198 - Pain Outcomes Following Intralesional Corticosteroid Injections Phase 4
Recruiting NCT02168634 - The Use of Botulinum Toxin in the Treatment of Itching From Hypertrophic Scar -- A Randomised Controlled Trial N/A
Completed NCT02030275 - A Study to Evaluate the Effectiveness and Safety of RXI 109 on the Outcome of Scar Revision Surgery in Healthy Adults Phase 2
Recruiting NCT04506255 - Silicone Taping for the Improvement of Abdominal Donor Site Scars N/A
Not yet recruiting NCT04593706 - Comparison of the Efficacy of Different Steroids in the Treatment of Abnormal Scars (Keloids, Hypertrophic Scars) N/A
Completed NCT04643223 - Effect of Elastic Bandage With Tension on the Inflammatory Response of Hypertrophic Scars N/A
Completed NCT03986346 - The Vascularity Changes of Scars With Laser Therapy N/A
Completed NCT04619589 - Characterization of Dyschromic Hypertrophic Scar
Completed NCT06347081 - Effect of Nd-YAG Laser on Hypertrophic Scar N/A
Completed NCT05412745 - Class I Medical Device on Post-surgical Scars N/A
Terminated NCT03403621 - Hypertrophic Scar Prevention by Novel Topical Gel Application Phase 1/Phase 2
Completed NCT00754247 - A Randomized Comparative Study Evaluating the Tolerability and Efficacy of Two Topical Therapies for the Treatment of Keloids and Hypertrophic Scars Phase 4
Recruiting NCT03692273 - Randomized Control Trial of CO2 Laser to Treat Hypertrophic Burn Scar N/A
Completed NCT03795116 - Light Emitting Diode-Red Light (LED-RL) Phototherapy for Skin Scarring Prevention Phase 2
Not yet recruiting NCT03850119 - Nanofat on Wound Healing and Scar Formation N/A